Silver Book Fact

Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349 in women 50- to 59-years-old, and $74,981 in women 60 to 69.

Joint Economic Committee. The Benefits of Medical Research and the Role of NIH. Apr-2000;

Reference

Title
The Benefits of Medical Research and the Role of NIH
Publisher
United States Senate: Office of the Chairman, Connie Mack
Publication Date
Apr-2000
Authors
Joint Economic Committee

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Death rates from breast cancer have steadily decreased in women since 1990. This decrease represents progress in both early detection and improved treatment.  
  • Use of an epidermal growth factor inhibitor in the treatment of metastatic colon cancer patients without the KRAS gene mutation saw survival rates of 15.6 months, compared to 5.6 months…  
  • The 5-year survival rate for all cancers diagnosed from 1996-2003 is 66%, up from 50% in 1975-1977. This improvement reflects progress in early diagnosis and improvements in treatment.  
  • FDA Cancer Approvals for Aug 2014 to July 2015
     
  • An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay…